MergerJul 29, 2026, 05:21 PM
BCAR Shareholders Approve Business Combination with Exascale Labs
AI Summary
D. Boral ARC Acquisition I Corp. (BCAR) shareholders approved the business combination with Exascale Labs Inc. at an Extraordinary General Meeting held on July 29, 2026. The combined company is expected to operate as Exascale Labs Holdings Inc. and trade on Nasdaq under "XLAB" and "XLABW". Approximately $12 million remains in BCAR's trust account after redemptions, satisfying the minimum cash closing condition, and no additional financing is anticipated before closing.
Key Highlights
- Shareholders approved the business combination with Exascale Labs.
- The combined entity will operate as Exascale Labs Holdings Inc.
- Shares are expected to trade on Nasdaq under ticker symbols "XLAB" and "XLABW".
- Approximately $12 million remains in BCAR's trust account after redemptions.
- The remaining trust amount satisfies the minimum cash closing condition.
- No additional financing is anticipated prior to closing the transaction.
- The Business Combination Proposal received 24,503,325 "FOR" votes.
- 62.28% of ordinary shares were represented at the Extraordinary General Meeting.
Price Impact
More from BCAR